Trade the next vector.
Price the outbreak in real time.
PredictHanta is an information market on the 2026 hantavirus situation. Resolve questions about WHO declarations, geographic spread, fatality counts and vaccine progress — settled against verifiable WHO, ECDC and PAHO sources.
- connecting…
- 09 May 2026 14:48·hantamap.online·monitoring
Tracker tick: case-count delta 0 over last 5 min. Static JSON feed re-validated against WHO DON #599 baseline.
- 09 May 2026 12:48·WHO · Geneva·verified
DON #599 update: global risk remains LOW. 14 confirmed Andes virus cases linked to MV Hondius; no IHR Emergency Committee convened.
- 09 May 2026 07:48·Switzerland · Zürich·verified
FOPH confirms 1 imported Andes virus case (Zürich resident, MV Hondius passenger). PCR + serology positive at reference lab Spiez.
Will WHO formally acknowledge sustained human-to-human Andes transmission in 2026?
Will an Andes/HPS vaccine candidate enter Phase 2 trials in 2026?
Will WHO assign a Greek-letter (or successor scheme) variant name to a hantavirus lineage in 2026?
Will any regulator grant emergency authorization to a hantavirus vaccine in 2026?
Will a 'lab-origin' hypothesis appear in any G7 intelligence or government statement on hantavirus by Dec 31?
Will a peer-reviewed paper confirm a hantavirus reinfection case in 2026?
Will WHO, NIH, or NICE formally recognize a 'post-hantavirus' chronic syndrome by Dec 31?
Rodent-borne RNA virus, two clinical syndromes
HFRS in Eurasia (CFR <1–15%); HPS in the Americas (CFR 30–60%). Andes virus is the only orthohantavirus with documented person-to-person spread.
Crowdsourced probability beats news cycles
When the WHO publishes a DON, the market price has often moved hours earlier. We aggregate that signal so policymakers, hedgers and curious humans can read it.
On-chain oracle, off-chain proof
Each market cites a primary public source (WHO DON, ECDC TESSy, MMWR, ClinicalTrials.gov). Disputes go to a 7-day arbitration window before settlement.